281 related articles for article (PubMed ID: 24498342)
1. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
Maurin H; Chong SA; Kraev I; Davies H; Kremer A; Seymour CM; Lechat B; Jaworski T; Borghgraef P; Devijver H; Callewaert G; Stewart MG; Van Leuven F
PLoS One; 2014; 9(2):e87605. PubMed ID: 24498342
[TBL] [Abstract][Full Text] [Related]
2. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
Terwel D; Muyllaert D; Dewachter I; Borghgraef P; Croes S; Devijver H; Van Leuven F
Am J Pathol; 2008 Mar; 172(3):786-98. PubMed ID: 18258852
[TBL] [Abstract][Full Text] [Related]
3. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
Siman R; Cocca R; Dong Y
PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
[TBL] [Abstract][Full Text] [Related]
4. Tauopathy differentially affects cell adhesion molecules in mouse brain: early down-regulation of nectin-3 in stratum lacunosum moleculare.
Maurin H; Seymour CM; Lechat B; Borghgraef P; Devijver H; Jaworski T; Schmidt MV; Kuegler S; Van Leuven F
PLoS One; 2013; 8(5):e63589. PubMed ID: 23704923
[TBL] [Abstract][Full Text] [Related]
5. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
7. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
Maurin H; Lechat B; Borghgraef P; Devijver H; Jaworski T; Van Leuven F
Eur J Neurosci; 2014 Jul; 40(2):2442-53. PubMed ID: 24754737
[TBL] [Abstract][Full Text] [Related]
8. Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits.
Harris JA; Koyama A; Maeda S; Ho K; Devidze N; Dubal DB; Yu GQ; Masliah E; Mucke L
PLoS One; 2012; 7(9):e45881. PubMed ID: 23029293
[TBL] [Abstract][Full Text] [Related]
9. Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.
Kremer A; Maurin H; Demedts D; Devijver H; Borghgraef P; Van Leuven F
J Neurosci; 2011 Dec; 31(49):18036-47. PubMed ID: 22159117
[TBL] [Abstract][Full Text] [Related]
10. Trans-synaptic spread of tau pathology in vivo.
Liu L; Drouet V; Wu JW; Witter MP; Small SA; Clelland C; Duff K
PLoS One; 2012; 7(2):e31302. PubMed ID: 22312444
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.
Crespo-Biel N; Theunis C; Borghgraef P; Lechat B; Devijver H; Maurin H; Van Leuven F
Neurobiol Dis; 2014 Jul; 67():119-32. PubMed ID: 24704314
[TBL] [Abstract][Full Text] [Related]
12. A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy.
Siman R; Lin YG; Malthankar-Phatak G; Dong Y
J Neuropathol Exp Neurol; 2013 Nov; 72(11):1062-71. PubMed ID: 24128676
[TBL] [Abstract][Full Text] [Related]
13. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
[TBL] [Abstract][Full Text] [Related]
14. A mouse model to study tau pathology related with tau phosphorylation and assembly.
Engel T; Lucas JJ; Hernández F; Avila J
J Neurol Sci; 2007 Jun; 257(1-2):250-4. PubMed ID: 17362999
[TBL] [Abstract][Full Text] [Related]
15. Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier.
Liu Y; Zhang S; Li X; Liu E; Wang X; Zhou Q; Ye J; Wang JZ
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043530
[TBL] [Abstract][Full Text] [Related]
16. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
Van der Jeugd A; Hochgräfe K; Ahmed T; Decker JM; Sydow A; Hofmann A; Wu D; Messing L; Balschun D; D'Hooge R; Mandelkow EM
Acta Neuropathol; 2012 Jun; 123(6):787-805. PubMed ID: 22532069
[TBL] [Abstract][Full Text] [Related]
17. Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.
Desai MK; Sudol KL; Janelsins MC; Mastrangelo MA; Frazer ME; Bowers WJ
Glia; 2009 Jan; 57(1):54-65. PubMed ID: 18661556
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
[TBL] [Abstract][Full Text] [Related]
19. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099
[TBL] [Abstract][Full Text] [Related]
20. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
